CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported ...
Research on perovskite nanocrystals (PNCs) has progressed rapidly in recent years due to their exceptional photophysical properties—including high ...
GUANGZHOU, China--(BUSINESS WIRE)--Bio-Thera Solutions (SHA: 688177), a commercial-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results